Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines

Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000829
Authors' recomendations: There is early evidence in the form of two systematic reviews and one RCT that TMS may offer improved clinical outcomes for patients with PTSD. There were no primary research studies found in the systematic review assessing the use of rTMS for treating patients with GAD. Four HTAs indicate that while evidence tends to demonstrate the effectiveness of rTMS, it is insufficient to draw conclusions regarding the use of TMS for treating patients with depression; additional systematic reviews and meta-analyses for the use of TMS for treating depression have also reported benefits. Five guideline documents include recommendations regarding the use of TMS in practice, but are variable between organizations.
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Anxiety
  • Anxiety Disorders
  • Combat Disorders
  • Depression
  • Depressive Disorder
  • Panic Disorder
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.